PubHawk
J Transl Med March 2024 PMID 38429794

The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.

Qilong Nie, Mingyang Li, Caiyang Huang, Yongwei Yuan, Qiuyan Liang, Xiaojun Ma, Tengyu Qiu, Jianhong Li

Full text PDF Download social card

Mentions

9
Peak: 1 in Aug 2024
across 4 sources since Aug 2024

Extended reach

16,363
potential audience

Total likes

808

Video views

12,893

Mentions per month

Aug 2024 – Aug 2025

Where it's discussed

  • X / Twitter3 posts
  • YouTube2 videos
  • Reddit2 posts
  • News2 articles

AI synopsis

What people are saying

The group's responses are limited, with one participant expressing approval in a brief manner, which reflects a basic positive sentiment but lacks detailed analysis or debate about the study's findings. The tone and phrasing suggest casual awareness rather than active, engaged discussion, contributing to the neutral scoring across the dimensions.

AgreementNeither agree nor disagree

The brief post stating 'Berberine is great' shows a positive attitude but doesn't deeply engage with the details or evidence of the publication, leading to a neutral agreement score.

InterestModerate interest

The mention of berberine's benefits suggests some interest, but overall, the discussions lack depth, resulting in a modest interest score.

EngagementNeutral engagement

The comments are minimal and do not delve into specifics, indicating a superficial level of engagement.

ImpactNeutral impact

Overall, these discussions do not seem to significantly influence broader community perceptions or clinical practices, resulting in a neutral impact score.

Abstract in brief

  • This meta-analysis assessed the effectiveness and safety of berberine in treating nonalcoholic fatty liver disease (NAFLD), analyzing data from 10 randomized controlled trials involving 811 patients, and found that berberine significantly improved various liver function markers, lipid profiles, insulin resistance, and body weight.
  • The study used extensive database searches up to September 2023 and employed statistical tools like Review Manager and STATA to analyze outcomes such as ALT, AST, GGT, triglycerides, cholesterol levels, insulin resistance, and BMI, showing consistent benefits of berberine in these areas.
  • Despite positive findings on multiple health indicators, the review emphasizes the need for further research to conclusively establish berberine's clinical efficacy and safety for NAFLD treatment.
Read the full abstract

Top posts

Most liked on X and Bluesky
Dave's not here, Man
@davidfamlawyer · X

@fmfclips Berberine is great: https://t.co/nv4FKU6KyP.

Sep 11, 2024 · 1 like · 1,511 followers View post →
James Tang
@James69888 · X

@paul_kazzi @LeddyLLC [10] https://t.co/9BdofRGSFW [11] https://t.co/kSNZO0hgFv [12] https://t.co/RM4fAZDoWr [13] https://t.co/xxFfKC53kz

Jun 8, 2025 · 1,608 followers View post →

All mentions

James Tang
@James69888 · X

@paul_kazzi @LeddyLLC [10] https://t.co/9BdofRGSFW [11] https://t.co/kSNZO0hgFv [12] https://t.co/RM4fAZDoWr [13] https://t.co/xxFfKC53kz

Jun 8, 2025 · 1,608 followers View post →
Dr. Nick Mawani, BSc, RRT, CNPA, MPH, DrPH, FRSPH.
@orcdcanada · X

https://t.co/8zn5rMid7Q

Feb 16, 2025 · 352 followers View post →
Dave's not here, Man
@davidfamlawyer · X

@fmfclips Berberine is great: https://t.co/nv4FKU6KyP.

Sep 11, 2024 · 1 like · 1,511 followers View post →